In psychopathology, the p-factor suggests the presence of a common factor driving various mental health disorders. A recent Translational Psychiatry study aimed to discover p-factor-related plasma ...

Markers associated with circulating endothelial cells (CEC) in advanced NSCLC: Prognostic value. Background: The aim of the study was to evaluate angiogenic plasma markers in patients with metastatic ...

A Quebec research team has discovered two early plasma markers to detect Alzheimer's disease five years before its onset. The results of this recent study led by the doctoral student Mohamed Raâfet ...

Plasma levels of neurofilament light (NfL) are a better predictor of cognitive decline and changes on neuroimaging in comparison with total tau (T-tau), new research suggests. In certain contexts, ...

A four-marker blood panel that includes two newly identified proteins detected stage I and II pancreatic cancer with 87.5 percent sensitivity at a 5 percent false-positive rate, according to findings ...

A randomized controlled trial found that older adults who completed structured cognitive-motor dual-task training showed a ...

In the NCI cohort, 14/16 (87.5%) patients exhibited ≥ 90% decrease in mutation abundance by the first on-treatment timepoint (20-28 days from treatment start) with minimal subsequent change. Similarly ...

How early in the course of Alzheimer’s disease can a blood marker detect amyloid pathology, and which marker does it best? At this year’s Alzheimer’s Association International Conference, held from ...

In an article published ahead of print on November 24, 2015 in the journal Diabetes (available at http://dx.doi.org/10.2337/db15-0930), researchers from the Medical ...

For years, scientists have been working toward blood tests for Alzheimer’s disease that could be used routinely in clinical practice. Now, they are on the cusp. At this year’s ADPD conference, held ...